ANL
Adlai Nortye Group Ltd. - American Depositary Shares (ANL)
$95
About Adlai Nortye Group Ltd. - American Depositary Shares (ANL)
Adlai Nortye Group Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Details
Daily high
$15.04
Daily low
$14.20
Price at open
$14.20
52 Week High
$17.25
52 Week Low
$0.88
Market cap
849.3M
Dividend yield
-
Volume
38,114
Avg. volume
155,209
P/E ratio
-26.63
Adlai Nortye Group Ltd. - American Depositary Shares News
Details
Daily high
$15.04
Daily low
$14.20
Price at open
$14.20
52 Week High
$17.25
52 Week Low
$0.88
Market cap
849.3M
Dividend yield
-
Volume
38,114
Avg. volume
155,209
P/E ratio
-26.63